Lataa...
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of several cancers, including breast cancer. In addition, dysregulation of PI3K signaling may contribute to resistance to several anticancer agents. PI3K inhi...
Tallennettuna:
| Julkaisussa: | Breast Cancer (Dove Med Press) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796458/ https://ncbi.nlm.nih.gov/pubmed/29430197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S134641 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|